41.
Extremophiles may be irrelevant to the origin of life
by Cleaves, 2nd, H James
Astrobiology, 2004, Vol.4 (1), p.1-9
42.
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
by Copland, Emma
The lancet oncology, 2021-04, Vol.22 (4), p.558-570
43.
Altered c-fos in Rostral Medulla and Spinal Cord of Spontaneously Hypertensive Rats
by Minson, Jane
Hypertension (Dallas, Tex. 1979), 1996-03, Vol.27 (3), p.433-441
44.
Genomewide Association Study Using a High-Density Single Nucleotide Polymorphism Array and Case-Control Design Identifies a Novel Essential Hypertension Susceptibility Locus in the...
by Salvi, Erika
Hypertension (Dallas, Tex. 1979), 2012-02, Vol.59 (2), p.248-+
45.
Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial
by Joshi, Rohina
Expert review of endocrinology & metabolism, 2009-03-01, Vol.4 (2), p.111-118
46.
Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us
by Chalmers, John P
American Journal of Hypertension, 2001, Vol.14 (S5), p.270S-275S
47.
48.
Blood Pressure Lowering for the Secondary Prevention of Myocardial Infarction and Stroke
by MacMahon, Stephen
Hypertension (Dallas, Tex. 1979), 1997-02, Vol.29 (2), p.537-538
49.
Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus results from action in diabetes and...
by Van Der Leeuw, Joep
Hypertension (Dallas, Tex. 1979), 2015-01-01, Vol.65 (1), p.115-121
50.
Trials on blood pressore-lowering and secondary stroke prevention: A Symposium: Managing Cardiovascular and Cerebrovascular Risk: Recent Data and the Promise of the ONTARGET Trial...
by CHALMERS, John
The American journal of cardiology, 2003, Vol.91 (10A), p.3G-8G
51.
Antimicrobial prophylaxis for endocarditis: Letter to the Editor (1)
by Chalmers, John A C
Heart (British Cardiac Society), 2007-06, Vol.93 (6), p.753
52.
The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
by HARRAP, Stephen B
Hypertension (Dallas, Tex. 1979), 2003, Vol.42 (3), p.297-303
53.
Blood Pressure Variables and Cardiovascular Risk: New Findings From ADVANCE
by Kengne, Andre-Pascal
Hypertension (Dallas, Tex. 1979), 2009-08, Vol.54 (2), p.399-404
54.
Lower Treatment Blood Pressure Is Associated With Greatest Reduction in Hematoma Growth After Acute Intracerebral Hemorrhage
by Arima, Hisatomi
Hypertension (Dallas, Tex. 1979), 2010-11, Vol.56 (5), p.852-858
55.
The lowering of blood pressure after stroke
by MacMahon, Stephen
The Lancet (British edition), 2001-12-08, Vol.358 (9297), p.1994-1995
56.
Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial
by Czernichow, Sébastien
Hypertension (Dallas, Tex. 1979), 2010-05, Vol.55 (5), p.1193-1198
57.
Systematic risk and the muni puzzle
by Chalmers, John M.R
National tax journal, 2006-12-01, Vol.LIX (4), p.833-848
58.
Antimicrobial prophylaxis for endocarditis: emotion or science?
by Ashrafian, H
Heart (British Cardiac Society), 2007-01, Vol.93 (1), p.5-6
59.
The ADVANCE trial – Authors' reply
by Patel, Anushka
The Lancet (British edition), 2008, Vol.371 (9606), p.26-26
60.
Tuesday, may 16, broadway ballroom north, 5:30 pm to 7:30 pm. ace inhibitors: More than just bp reduction: Connecting the dots: Ongoing ace inhibition trials and what they can tell...
by John Chalmers
American journal of hypertension, 2000-04, Vol.13 (S2), p.325A-325A
